SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-012798
Filing Date
2017-06-21
Accepted
2017-06-21 16:23:12
Documents
4
Period of Report
2017-06-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sbph-8k_20170621.htm 8-K 30940
2 OFFERING PRESS RELEASE sbph-ex991_7.htm EX-99.1 12370
3 PROSPECTUS SUPPLEMENT BUSINESS SUMMARY sbph-ex992_6.htm EX-99.2 25744
4 GRAPHIC g201706211852047163872.jpg GRAPHIC 5029
  Complete submission text file 0001564590-17-012798.txt   77210
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 17923113
SIC: 2834 Pharmaceutical Preparations